BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 33842194)

  • 21. Parasitic infections in HIV infected individuals: diagnostic & therapeutic challenges.
    Nissapatorn V; Sawangjaroen N
    Indian J Med Res; 2011 Dec; 134(6):878-97. PubMed ID: 22310820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parasitic Infections Associated with Unfavourable Outcomes in Transplant Recipients.
    Wołyniec W; Sulima M; Renke M; Dębska-Ślizień A
    Medicina (Kaunas); 2018 May; 54(2):. PubMed ID: 30344258
    [No Abstract]   [Full Text] [Related]  

  • 23. Intestinal Parasitic Infection and Associated Risk Factors among HIV-Infected Patients Seeking Healthcare in a Rural Hospital in Ghana.
    Deku JG; Botchway KA; Kinanyok S; Gedzeah CK; Duneeh RV; Duedu KO
    J Pathog; 2022; 2022():5652637. PubMed ID: 36046216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual Inhibition of Parasitic Targets: A Valuable Strategy to Treat Malaria and Neglected Tropical Diseases.
    Previti S; Di Chio C; Ettari R; Zappalà M
    Curr Med Chem; 2022; 29(17):2952-2978. PubMed ID: 34375176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastrointestinal Parasitic Infections and Immunological Status of HIV/AIDS Coinfected Individuals in Nigeria.
    Udeh EO; Obiezue RNN; Okafor FC; Ikele CB; Okoye IC; Otuu CA
    Ann Glob Health; 2019 Jul; 85(1):. PubMed ID: 31276332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and associated factors of intestinal parasitic infections among HIV clients attending Masaka Regional Referral Hospital, Uganda.
    Mwebaza S; Senyonga B; Atuhairwe C; Taremwa IM
    Pan Afr Med J; 2022; 43():122. PubMed ID: 36762162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Women and HIV. Epidemiology and global overview.
    Fowler MG; Melnick SL; Mathieson BJ
    Obstet Gynecol Clin North Am; 1997 Dec; 24(4):705-29. PubMed ID: 9430163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How common is intestinal parasitism in HIV-infected patients in Malaysia?
    Asma I; Johari S; Sim BL; Lim YA
    Trop Biomed; 2011 Aug; 28(2):400-10. PubMed ID: 22041762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of interaction between protozoan parasites and HIV.
    Andreani G; Lodge R; Richard D; Tremblay MJ
    Curr Opin HIV AIDS; 2012 May; 7(3):276-82. PubMed ID: 22418447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consequences of HIV infection on malaria and therapeutic implications: a systematic review.
    Flateau C; Le Loup G; Pialoux G
    Lancet Infect Dis; 2011 Jul; 11(7):541-56. PubMed ID: 21700241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neglected tropical diseases in Central America and Panama: review of their prevalence, populations at risk and impact on regional development.
    Hotez PJ; Woc-Colburn L; Bottazzi ME
    Int J Parasitol; 2014 Aug; 44(9):597-603. PubMed ID: 24846528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral drug therapy for multiple neglected tropical diseases: a systematic review.
    Reddy M; Gill SS; Kalkar SR; Wu W; Anderson PJ; Rochon PA
    JAMA; 2007 Oct; 298(16):1911-24. PubMed ID: 17954542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parasite associations predict infection risk: incorporating co-infections in predictive models for neglected tropical diseases.
    Clark NJ; Owada K; Ruberanziza E; Ortu G; Umulisa I; Bayisenge U; Mbonigaba JB; Mucaca JB; Lancaster W; Fenwick A; Soares Magalhães RJ; Mbituyumuremyi A
    Parasit Vectors; 2020 Mar; 13(1):138. PubMed ID: 32178706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Interplay of Host Microbiota and Parasitic Protozoans at Mucosal Interfaces: Implications for the Outcomes of Infections and Diseases.
    Bär AK; Phukan N; Pinheiro J; Simoes-Barbosa A
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004176. PubMed ID: 26658061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug treatment of tropical parasitic infections: recent achievements and developments.
    Stephenson I; Wiselka M
    Drugs; 2000 Nov; 60(5):985-95. PubMed ID: 11129130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Opportunistic Intestinal Parasitic Infections Among HIV/AIDS Patients Before and After Commencement of Antiretroviral Treatment at Felege Hiwot Referral Hospital: A Follow-up Study.
    Getachew T; Hailu T; Alemu M
    HIV AIDS (Auckl); 2021; 13():767-774. PubMed ID: 34295192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal parasitic infections and its association with undernutrition and CD4 T cell levels among HIV/AIDS patients on HAART in Butajira, Ethiopia.
    Gedle D; Kumera G; Eshete T; Ketema K; Adugna H; Feyera F
    J Health Popul Nutr; 2017 May; 36(1):15. PubMed ID: 28506307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of neglected parasitic diseases in the era of COVID-19 pandemics.
    Sharbatkhori M; Montazeri M; Besharat S; Fakhar M
    Ann Parasitol; 2022; 68(4):667-672. PubMed ID: 37573497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal parasitic infections in relation to CD4(+) T cell counts and diarrhea in HIV/AIDS patients with or without antiretroviral therapy in Cameroon.
    Nsagha DS; Njunda AL; Assob NJC; Ayima CW; Tanue EA; Kibu OD; Kwenti TE
    BMC Infect Dis; 2016 Jan; 16():9. PubMed ID: 26754404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents.
    Al Jalali V; Zeitlinger M
    Clin Pharmacokinet; 2020 Jul; 59(7):827-847. PubMed ID: 32100246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.